ARCHIVES

A Take-Home Message From ASCO 2014: NCI-Funded Clinical Research In Jeopardy,bSociety Focuses on Value of NCTN Groups

This article is from The Cancer Letter archive.

Vol. 40 No. 23 | June 6, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.

November 19, 2004

Hiring Freeze Squeezes NIH, NCI

August 3, 1979

Nancy Davidson Named Director Of UPCI, Succeeding Herberman.

November 21, 2008

PRI, Fending Off More Giants, Reportedly wins New operations. Support contract at Frederick

July 10, 1987